Skip to main content
Erschienen in: Neurological Sciences 9/2022

31.05.2022 | Review Article

Autoimmune encephalitis and CSF anti-AMPA GluR3 antibodies in childhood: a case report and literature review

verfasst von: Maria Elena Cucuzza, Piero Pavone, Angela D’Ambra, Maria Carla Finocchiaro, Filippo Greco, Pierluigi Smilari, Martino Ruggieri, Vita Antonella Di Stefano

Erschienen in: Neurological Sciences | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Acute autoimmune encephalitis is a severe neurological disorder presenting with altered level of consciousness, confusion, irritability, headache, vomiting, and in some cases seizures. An infective event precedes by 1–2 weeks the onset of the symptoms. Cognitive impairment is considered the cardinal symptom. The autoimmune encephalitis comprises an increasingly group of inflammatory brain disorder caused by an underlying abnormal immune response to the CNS to the infective agent. In children, several antibodies have been recorded as causative agent. Among these, GAD65, MOG, and NMDAR antibodies are more commonly reported and with less frequency, the Dopamine-2 receptor, GABA A receptor, GABA B receptor, and Glycinereceptorandm-GluR5. We report here a 10-year-old male with acute autoimmune encephalitis with altered status of consciousness and severe cerebral involvement at the brain-MRI. Serum and cerebrospinal fluid disclosed the presence of anti-AMPA-GluR3 antibodies suggesting a possible pathogenetic correlation with the disorder presented by the proband. Precocious treatment with intravenous methylprednisolone and immunoglobulin resulted in progressive but constant improvement. At 3-month follow-up, the clinical condition of the child and the neuro-radiological brain anomalies returned to the normal. At the 2-year follow-up, no recurrence or other disturbances were reported.
Literatur
1.
Zurück zum Zitat Said S, Kang M (2021) Viral encephalitis. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing Said S, Kang M (2021) Viral encephalitis. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing
2.
Zurück zum Zitat Erickson T, Musca l, Munoz F et al (2020) Infectious and autoimmune causes of encephalitis in children. Pediatrics 145(6) Erickson T, Musca l, Munoz F et al (2020) Infectious and autoimmune causes of encephalitis in children. Pediatrics 145(6)
3.
Zurück zum Zitat Dubey D, Pittock S, Krecke K et al (2019) Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 76(3):301–309CrossRef Dubey D, Pittock S, Krecke K et al (2019) Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 76(3):301–309CrossRef
4.
Zurück zum Zitat de Bruijn M, Bruijstens A, Bastiaansen A et al (2020) Pediatric autoimmune encephalitis: recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm 7(3):e682CrossRef de Bruijn M, Bruijstens A, Bastiaansen A et al (2020) Pediatric autoimmune encephalitis: recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm 7(3):e682CrossRef
5.
Zurück zum Zitat Cellucci T, Van Mater H, Graus F et al (2020) Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm 7(2):e663CrossRef Cellucci T, Van Mater H, Graus F et al (2020) Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm 7(2):e663CrossRef
6.
Zurück zum Zitat Dutra L, Abrantes F, Toso F et al (2018) Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 76(1):41–49CrossRef Dutra L, Abrantes F, Toso F et al (2018) Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 76(1):41–49CrossRef
7.
Zurück zum Zitat Abboud H, Probasco J, Irani S et al (2021) Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92(7):757–768CrossRef Abboud H, Probasco J, Irani S et al (2021) Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92(7):757–768CrossRef
8.
Zurück zum Zitat Hacohen Y, Wright S, Waters P et al (2013) Paediatric autoimmune encephalopathies: clinical features, laboratory investigation sand out comesin patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 84(7):748–55CrossRef Hacohen Y, Wright S, Waters P et al (2013) Paediatric autoimmune encephalopathies: clinical features, laboratory investigation sand out comesin patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 84(7):748–55CrossRef
9.
Zurück zum Zitat Levite M (2014) Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies oranti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren’s syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor’s expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. J NeuralTransm 121(8):1029–75 Levite M (2014) Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies oranti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren’s syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor’s expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy. J NeuralTransm 121(8):1029–75
10.
Zurück zum Zitat Spatola M, Pedrol M, Maudes E et al (2020) Clinical features, prognostic factors, and antibody effects in anti-mGluR1encephalitis. Neurology 95(22):e3012–e3025CrossRef Spatola M, Pedrol M, Maudes E et al (2020) Clinical features, prognostic factors, and antibody effects in anti-mGluR1encephalitis. Neurology 95(22):e3012–e3025CrossRef
11.
Zurück zum Zitat Lancaster E, Martinez-Hernandez E, Titulaer M (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77(18):1698–1701CrossRef Lancaster E, Martinez-Hernandez E, Titulaer M (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77(18):1698–1701CrossRef
12.
Zurück zum Zitat Guevara C, Farias G, Silva-Rosas C et al (2018) Encephalitis associated to metabotropic glutamate receptor 5 (mGluR5) antibodies in cerebrospinal fluid. Front Immunol 9:2568CrossRef Guevara C, Farias G, Silva-Rosas C et al (2018) Encephalitis associated to metabotropic glutamate receptor 5 (mGluR5) antibodies in cerebrospinal fluid. Front Immunol 9:2568CrossRef
13.
Zurück zum Zitat Scherer S, Duvoisin R, Kuhn R et al (1996) Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. Genomics 31(2):230–233CrossRef Scherer S, Duvoisin R, Kuhn R et al (1996) Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. Genomics 31(2):230–233CrossRef
14.
Zurück zum Zitat Saini S, Mancuso S, Mostaid S et al (2017) Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Transl Psychiatry7(8) Saini S, Mancuso S, Mostaid S et al (2017) Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Transl Psychiatry7(8)
15.
Zurück zum Zitat Fromer M, Pocklington AJ, Kavanagh DH et al (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506(7487):179–84CrossRef Fromer M, Pocklington AJ, Kavanagh DH et al (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506(7487):179–84CrossRef
16.
Zurück zum Zitat Kandaswamy R, McQuillin A, Sharp SI et al (2013) Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 70(6):591–8CrossRef Kandaswamy R, McQuillin A, Sharp SI et al (2013) Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 70(6):591–8CrossRef
17.
Zurück zum Zitat Mantegazza R, Bernasconi P, Baggi F et al (2002) Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 131(1–2):179–185CrossRef Mantegazza R, Bernasconi P, Baggi F et al (2002) Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 131(1–2):179–185CrossRef
18.
Zurück zum Zitat Buscarinu M, Fornasiero A, Pellicciari G et al (2019) Autoimmune encephalitis and CSF anti-GluR3 antibodies in an MS patient after alemtuzumab Buscarinu M, Fornasiero A, Pellicciari G et al (2019) Autoimmune encephalitis and CSF anti-GluR3 antibodies in an MS patient after alemtuzumab
Metadaten
Titel
Autoimmune encephalitis and CSF anti-AMPA GluR3 antibodies in childhood: a case report and literature review
verfasst von
Maria Elena Cucuzza
Piero Pavone
Angela D’Ambra
Maria Carla Finocchiaro
Filippo Greco
Pierluigi Smilari
Martino Ruggieri
Vita Antonella Di Stefano
Publikationsdatum
31.05.2022
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 9/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06170-0

Weitere Artikel der Ausgabe 9/2022

Neurological Sciences 9/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.